Patient Selection Criteria and Management Guidelines for Outpatient Parenteral Antibiotic Therapy for Native Valve Infective Endocarditis
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Outpatient parenteral antibiotic therapy (OPAT) for infective endocarditis (IE) is being applied widely, despite the absence of controlled data that demonstrates that outcomes are equivalent to those with standard inpatient antibiotic therapy. We review existing OPAT guidelines, published data on the timing of complications from IE, and data on risk factors that can be used to predict complications. These data are used to propose more stringent criteria for patient selection and clinical management of OPAT for native valve IE. We recommend a conservative approach (inpatient or daily outpatient follow-up) during the critical phase (weeks 0-2 of treatment), when complications are most likely, and we recommend consideration of OPAT for the continuation phase (weeks 2-4 or 2-6 of treatment) when life-threatening complications are less likely.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Textbook of Cardiovascular Medicine
Topol, E. J. (1997) · Cited by 961
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723 · cited 1×
“Transesophageal echocardiography has dramatically improved detection of perivalvular abscess, with a sensitivity of 87% and a specificity of 95%, compared with a sensitivity of 28% and a specificity of 99% for transthoracic echocardiography [80].”
BackgroundMügge, A., Daniel, W. G., Frank, G., & Lichtlen, P. R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90104-6 · Cited by 654
Infective Endocarditis in the Antibiotic Era
Lerner, P. I., & Weinstein, L. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601272740407 · Cited by 595 · cited 2×
“Heart failure due to valvular insufficiency is the leading complication of IE; it occurs in 15%–65% of cases [40, 52, 53, 63].”
BackgroundWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · cited 2×
“According to the American Heart Association Guidelines for IE treatment [10], “inpatient therapy does not prevent.”
MethodNEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Emboli in Infective Endocarditis: The Prognostic Value of Echocardiography
Steckelberg, J. M., Murphy, J. G., Ballard, D., Bailey, K., Tajik, A. J., Taliercio, C. P., Giuliani, E. R., & Wilson, W. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-8-635 · Cited by 411 · cited 2×
“to those of mitral valve vegetations [66].”
BackgroundTreatment of infective endocarditis: a 10-year comparative analysis.
Richardson, J. V., Karp, R. B., Kirklin, J. W., & Dismukes, W. E. (1978) · Circulation · doi:10.1161/01.cir.58.4.589 · Cited by 362 · cited 1×
“aureus is the pathogen most often associated with abscess [39, 77].”
BackgroundSanfilippo, A. J., Picard, M. H., Newell, J. B., Rosas, E., Davidoff, R., Thomas, J. D., & Weyman, A. E. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90535-h · Cited by 328
Research works printed but not linked: 18
- Wilson WR, 1982, Mayo Clin Proc, 57, 162
- Dismukes WE, 1981, Philadelphia: FA Davis, 189
- Scheld WM, 1995, New York: Churchill Livingstone, 740
- Patton J. Infective endocarditis: economic considerations. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:413-422.
- Gentry LO, 1989, Tex Heart Inst J, 16, 250
- Antoniskis A, 1978, West J Med, 128, 203
- Rehm SJ, 1986, New York: Marcel Dekker, 117
- Stiver HG, 1982, Can Med Assoc J, 127, 207
- Francioli PB, 1993, Philadelphia: WB Saunders, 97
- Kunkel MJ, 1996, Chicago: Scientific American, 60
- Rehm SJ, 1998, Philadelphia: WB Saunders, 879
- 10.1001/archinte.152.9.1863 · doi:10.1001/archinte.152.9.1863 · Paper page
- Karchmer AW. Staphylococcal endocarditis. In: Kaye D, ed. Infective endocarditis. New York: Raven Press, 1992:225-249.
- Thompson RL, 1982, Mayo Clin Proc, 57, 106
- Karchmer AW, 1997, Philadelphia: WB Saunders, 1077
- Levinson ME. Response to therapy. In: Kaye D, ed. Infective endocarditis. Baltimore: University Park Press, 1976:185-199.
- Wilson WR, 1982, Mayo Clin Proc, 57, 155
- Schaff HV, 1986, New York: Marcel Dekker, 229
Cited by
Items 101–132 of 132
Pallasch, J., Takahashi, M., Taubert, K. A., Shulman, S. T., Burns, J. C., Falace, D. A., Newburger, J. W., Gewitz, H.-S., Tong, D., Steckelberg, J. M., et al. (2007) · Cited by 3
Melzer, M., Macpherson, L., & Welch, C. A. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134441 · Cited by 4
“Overall, there is little in the literature on the value of Microbiological results in patient identification with the emphasis on clinical and risk assessment and safe delivery of treatment((7,12)).”
BackgroundSuzuki, J. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20180040 · Cited by 3
Daptomicina en el paciente con hospitalización a domicilio
Ramallo, V. J. G. (2010) · Medicina Clínica · doi:10.1016/s0025-7753(10)70040-3 · Cited by 4
Tratamientos antibióticos parenterales en domicilio en la endocarditis infecciosa. Situación actual
Sánchez, M. Á. G. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.10.004 · Cited by 4
Brusch, J. L. (2007) · Infectious disease and therapy · doi:10.3109/9781420019834.014 · Cited by 2
Outpatient Parenteral Antimicrobial Therapy
Tice, A. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00048-5 · Cited by 1
Vito, L. D., D’Amato, G., Pascucci, R., D’Antonio, A., Scalone, G., Boni, M., Rossi, B., Cimaroli, I., Acciarri, C., Andreucci, M., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13040155 · Cited by 1
“Early recommendations, such as the 2001 Infectious Diseases Society of America (IDSA) criteria, were intentionally conservative [104].”
Daptomicina en el tratamiento antimicrobiano parenteral ambulatorio
Cervera, C., & Mestres, C. A. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(12)70074-5 · Cited by 1
Prophylaxis of infective endocarditis
Sakač, D., Kovačević, D., & Sekulić, S. (2011) · Medicinski pregled · doi:10.2298/mpns1106319s · Cited by 1
Outpatient Parenteral Antimicrobial Therapy
Hsueh, K., & Greene, J. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00053-9 · Cited by 1
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73540-6 · Cited by 3
Current trends in infective endocarditis
Pazderník, M. (2022) · Intervenční a akutní kardiologie · doi:10.36290/kar.2022.004 · Cited by 1
Kaplan, S. L., & Vallejo, J. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00026-1 · Cited by 1
Diagnosis and Management of Infective Endocarditis
Camitta, M. G. W., Geme, J. W. S., & Li, J. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_4 · Cited by 1
Halpern, S. D., Abrutyn, E., & Strom, B. L. (2009) · Wiley eBooks · doi:10.1002/9781444301601.ch4 · Cited by 1
Karchmer, A. W. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-918-9_31 · Cited by 1
Manejo de las enfermedades infecciosas en el medio extrahospitalario
Soriano, A. S., Lillo, J. A. A., Ballesteros, J., & Ramallo, V. J. G. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70032-9 · Cited by 1
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
L'endocardite infectieuse (2e partie)
Cavassini, M., Eggimann, P., Moreillon, P., & Francioli, P. B. (2002) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2002.04614
Infektiöse Endokarditis (Teil 2)
Cavassini, M., Eggimann, P., Moreillon, P., & Francioli, P. B. (2002) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2002.04614 · Cited by 3
D’Couto, H. T. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Non-inpatient parenteral antimicrobial therapy
Nathwani, D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00133-7
Starke, J. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50037-6
Ricketts, J. C., & Jacob, J. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-47868-1_15
Endocarditis and Other Intravascular Infections
Kronman, M. P., & Dolgner, S. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00037-9
Multidisciplinary Team Approach to Management of Endocarditis: A Team of Teams
Rehm, S. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65839-6_4
Antibiotic therapy in the infective endocarditis: from intravenous to oral administration
Crociani, P. (2025) · Cardiologia Ambulatoriale · doi:10.17473/1971-6818-2025-1-4
Giants in infectious diseases: Prof. Jose M. Miró’s translational research in infective endocarditis
Pericàs, J. M., López-Montesinos, I., Ambrosioni, J., Cuervo, G. L., García-de-la-Mària, C., Meneses, M. H., Mestres, C. A., Moreno, A., & Miró, J. M. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.11.017
Vivero Larraza, A. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Hozayen, J., Hozayen, O., Behers, B. J., Riveros, N., Jad, A. A. A., Roumia, B., Stephenson-Moe, C. A., Miller, M. W., & Hamad, K. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124738
“This transition typically occurs within the first 1 to 2 weeks of hospitalization once patients have cleared bacteremia, demonstrated hemodynamic stability, and met other established criteria for OPAT candidacy [14].”
Roland, T., & Yombi, J. C. (2026) · Pathogens · doi:10.3390/pathogens15090924
“The 2015 guidelines of the ESC and the American Heart Association (AHA) acknowledged outpatient parenteral antimicrobial therapy or, in selected cases, oral step-down therapy, although supporting evidence remained limited at that time [1,2,18,19].”
Metadata
- Authors
- Andrews, M., & von Reyn, C. F.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07-15
- Volume
- 33
- Issue
- 2
- Pages
- 203-209
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2129274686
- Cited by
- 129
- References
- 82
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 2 · 2013: 11 · 2012: 7
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Keywords
- outpatient parenteral antibiotic therapy, infective endocarditis, native valve endocarditis, patient selection criteria, treatment phases, risk factors, conservative treatment, antibiotic therapy
- MeSH terms
- Anti-Bacterial Agents, Endocarditis, Bacterial, Health Planning Guidelines, Heart Valves, Humans, Outpatients, Practice Guidelines as Topic, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.